FIG. 4.

Distribution of the transcription-mediated chimera expression. (A) The distribution of USP9Y-TTTY15 expression level in the Chinese prostate cancer and adjacent nonmalignant tissues overall and in different clinical subgroups. (B) The distribution of SLC45A3-ELK4 expression level in the Chinese prostate cancer and adjacent nonmalignant tissues, split into different groups based on clinical parameters. The expression level of USP9Y-TTTY15 and SLC45A3-ELK4 (y axis) was presented in n fold change relative to sample 31C (setting the expression level at 1). Age, age of the patient at diagnosis; GS, Gleason score; PSA, prostate specific antigen.